Online citations, reference lists, and bibliographies.
← Back to Search

Advances In Personalized Nanotherapeutics

A. Kaushik, R. Jayant, M. Nair
Published 2017 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
In this chapter, we start with the origin of nanotechnology and nanomedicine and the definition of nanomedicine in the USA and Europe. The size range of nanomedicine is discussed according to different definitions and regulations, and development of nanomedicine from lab to market is reviewed. Nanomaterials for nanomedicine is divided into two categories of polymer-based and metal-based. A brief explanation of most important nanomaterials including liposome, carbohydrates, gold, silver, and iron oxide in drug delivery and release, sensing and imaging are given. Nanomedicines already showed their potential and are promising to cure cancer, neurodegenerative disorders including NeuroHIV, Alzheimer’s, and Parkinson’s.
This paper references
10.1016/j.carbpol.2014.09.094
Glycerophosphate-based chitosan thermosensitive hydrogels and their biomedical applications.
Hui Yun Zhou (2015)
10.1021/MP060032E
Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
B. Boyd (2006)
10.1039/c0cc02577a
Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell.
Fenghua Chen (2010)
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.
L. Fenart (1999)
10.1074/jbc.274.11.7011
Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier*
C. Fillebeen (1999)
10.1016/j.ijpharm.2008.03.023
A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel.
M. Gou (2008)
10.1039/C1JM10631G
Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release
Baisong Chang (2011)
10.1016/j.biomaterials.2008.09.061
The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials.
J. Yin (2009)
10.1007/s11060-011-0763-6
Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs
Yuejun Fu (2011)
10.1016/S0006-291X(88)81333-0
Liposome targeting to mouse brain: mannose as a recognition marker.
F. Umezawa (1988)
10.1038/srep02534
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
Huile Gao (2013)
10.1021/nn1034873
Multistimuli responsive supramolecular vesicles based on the recognition of p-Sulfonatocalixarene and its controllable release of doxorubicin.
K. Wang (2011)
10.1002/open.201200003
Dual Enzyme-Triggered Controlled Release on Capped Nanometric Silica Mesoporous Supports
A. Agostini (2012)
10.1038/nmat2859
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
D. S. Wilson (2010)
10.5138/IJDD.2010.0975.0215.02006
Primary and novel approaches for colon targeted drug delivery - A review
G. Tiwari (2010)
10.1023/A:1015821504229
Electric Current-Sensitive Drug Delivery Systems Using Sodium Alginate/Polyacrylic Acid Composites
S. H. Yuk (2004)
10.1002/jbm.a.31866
Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization.
K. Yang (2009)
10.1021/jm800767c
Conjugated chitosan as a novel platform for oral delivery of paclitaxel.
E. Lee (2008)
10.1038/srep29247
Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats
M. Shevtsov (2016)
10.1080/10611860701289875
Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier
Zhi-Xiang Yuan (2007)
10.1016/J.EJPB.2014.10.017
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
D. Chirio (2014)
10.1021/bm201588m
Triply triggered doxorubicin release from supramolecular nanocontainers.
X. J. Loh (2012)
10.1007/978-1-59745-210-6_8
2B-Trans technology: targeted drug delivery across the blood-brain barrier.
P. Gaillard (2008)
10.1111/cbdd.12268
Novel Central Nervous System Drug Delivery Systems
Jocelyn Stockwell (2014)
Transferrinmodified liposome promotes α-mangostin to penetrate the blood–brain barrier. Nanomedicine
Chen Z-L (2016)
10.1038/nnano.2011.166
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.
H. Cabral (2011)
10.1093/HUMUPD/6.5.419
Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.
M. Dören (2000)
10.1007/s13346-016-0293-z
Nano-ART and NeuroAIDS
M. Das (2016)
10.1093/neuonc/noq054
Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment.
P. Chen (2010)
10.1016/S0168-3659(02)00084-6
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
H. Tozaki (2002)
10.1016/j.jconrel.2010.11.014
Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain.
I. van Rooy (2011)
Dendrimers and other dendritic macromolecules: From building blocks to functional assemblies in nanoscience and nanotechnology
J. Chet (2003)
10.1016/j.ijpharm.2011.09.008
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.
Yao Qin (2011)
10.1007/s11095-013-1122-4
Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
Huile Gao (2013)
10.1016/j.tox.2008.01.005
Nanostructures of hydrated C60 fullerene (C60HyFn) protect rat brain against alcohol impact and attenuate behavioral impairments of alcoholized animals.
A. Tykhomyrov (2008)
10.1021/ja809475a
Multi-stimuli sensitive amphiphilic block copolymer assemblies.
Akamol Klaikherd (2009)
10.1016/J.BIOMATERIALS.2007.06.011
Active targeting of brain tumors using nanocarriers.
A. Béduneau (2007)
10.1023/A:1012098005098
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
R. Alyautdin (2004)
10.1016/S0168-3659(03)00303-1
Electro-responsive drug delivery from hydrogels.
S. Murdan (2003)
Triggered release hydrogel drug delivery system
A Rosenthal (2003)
10.1016/J.FOODHYD.2005.10.015
Chitosan and glycerophosphate concentration dependence of solution behaviour and gel point using small amplitude oscillatory rheometry
Jaepyoung Cho (2006)
10.1016/j.bbrc.2010.03.024
Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis.
Mina Tamaru (2010)
10.1186/1423-0127-19-14
Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors
Yongling Xie (2011)
10.1038/nrc2818
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
J. Huse (2010)
10.1111/J.1527-3458.2007.00014.X
DP-155, a lecithin derivative of indomethacin, is a novel nonsteroidal antiinflammatory drug for analgesia and Alzheimer's disease therapy.
E. Dvir (2007)
10.2174/156800912799277557
Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.
T. Taylor (2012)
10.1016/j.biomaterials.2010.09.065
The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas.
M. Hua (2011)
10.1016/S0167-7799(01)01814-5
Personalized medicine: revolutionizing drug discovery and patient care.
G. Ginsburg (2001)
10.1002/jps.24002
Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Luigi Battaglia (2014)
10.3390/nano5042231
Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge
M. Busquets (2015)
10.1158/1078-0432.CCR-10-0387
Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
T. Hamaguchi (2010)
Prodrugs targeting the central nervous system (cns)
Falasteen Salameh (2015)
10.1016/j.jconrel.2012.01.031
Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation.
P. Zhang (2012)
10.1186/1479-5876-6-80
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
H. Sarin (2008)
10.1124/MOL.61.4.729
Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.
H. Uchino (2002)
[Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles].
R. N. Aliautdin (1996)
10.1021/acsnano.5b03874
Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics.
P. Huang (2015)
10.1073/PNAS.94.17.9434
Carboxyfullerenes as neuroprotective agents.
L. Dugan (1997)
10.1016/j.jconrel.2005.10.006
Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors.
D. Furgeson (2006)
10.1016/S0169-409X(98)00064-7
In vivo efficacy and safety of skin electroporation.
Vanbever (1999)
10.1016/J.IJPHARM.2005.01.043
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
W. Lu (2005)
10.1002/ijc.22732
Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound
Lisa Treat (2007)
10.1016/j.brainres.2008.07.121
VEGF increases blood–brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice
I. Ay (2008)
10.1007/978-1-4419-0769-1
Textbook of Personalized Medicine
K. Jain (2009)
10.1016/j.biomaterials.2009.01.003
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.
E. Allard (2009)
10.1016/j.ijpharm.2010.11.001
Oral drug delivery in personalized medicine: unmet needs and novel approaches.
K. Wening (2011)
10.1016/0378-5173(94)90369-7
Development of a novel drug delivery system, time-controlled explosion system (TES): V. Animal pharmacodynamic study and human bioavailability study
T. Hata (1994)
10.1038/mt.2013.190
Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit.
B. Wang (2014)
10.1016/J.JCONREL.2003.08.006
Brain uptake of thiamine-coated nanoparticles.
P. Lockman (2003)
10.2174/157488912798842241
Lipid-based nanocarriers for CNS-targeted drug delivery.
Maria-Rita Micheli (2012)
10.1039/C2JM31392H
Nanodesigned magnetic polymer containers for dual stimuli actuated drug controlled release and magnetic hyperthermia mediation
P. Bilalis (2012)
10.1016/J.BIOMATERIALS.2006.08.044
Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering.
K. E. Crompton (2007)
Drug Delivery to the Central Nervous System: A Review
R. Tamargo (1992)
10.1093/NEUONC/NOU087
The epidemiology of glioma in adults: a "state of the science" review.
Q. Ostrom (2014)
10.1073/pnas.1018790108
Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability
Myunghwan Choi (2011)
10.1002/CHIN.198432300
A COLON-SPECIFIC DRUG-DELIVERY SYSTEM BASED ON DRUG GLYCOSIDES AND THE GLYCOSIDASES OF COLONIC BACTERIA
D. Friend (1984)
10.1016/S0168-3659(03)00231-1
Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect.
Yoen Ju Son (2003)
10.1038/srep10560
Enzyme-activated intracellular drug delivery with tubule clay nanoformulation
M. Dzamukova (2015)
10.1021/mp200600t
Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy.
P. Zhang (2012)
10.4103/0250-474X.41446
Strategies for Enhanced Drug Delivery to the Central Nervous System
V. S. N. M. Dwibhashyam (2008)
10.1038/354291A0
Electrically credible polymer gel for controlled release of drugs
I. C. Kwon (1991)
10.1016/S0168-0102(02)00056-1
Local carboxyfullerene protects cortical infarction in rat brain
A. Lin (2002)
10.1038/mtna.2013.30
Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment
Pedro M. M. Costa (2013)
10.1016/j.biomaterials.2016.05.044
Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.
Elizabeth A. Nance (2016)
10.1016/j.addr.2011.11.007
Prodrug approaches to reduce hyperexcitation in the CNS.
Devaiah Vytla (2012)
Synthesis of dendrimer molecules based on triazine
Jannat FT-E (2006)
10.1002/jps.21487
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
R. Yang (2009)
10.1038/jcbfm.2012.209
Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury
Xiang Yun (2013)
10.1007/s13204-013-0216-y
Magnetic nanoparticle drug delivery systems for targeting tumor
V. Mody (2013)
10.1016/S0168-3659(99)00015-2
Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution.
K. Ogawara (1999)
10.1016/S0167-7799(01)01811-X
Drug discovery of the future: the implications of the human genome project.
T. Reiss (2001)
10.3171/FOC.2006.20.4.7
Convection-enhanced delivery of therapeutics for brain disease, and its optimization.
R. Raghavan (2006)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.1016/0009-2509(95)00344-4
Pressure dependence of the volume phase-transition of temperature-sensitive gels
X. Zhong (1996)
10.1016/j.copbio.2009.02.008
Infrared multiphoton microscopy: subcellular-resolved deep tissue imaging.
V. Andresen (2009)
10.1093/neuonc/nov189
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Q. Ostrom (2015)
10.1021/acsnano.5b03975
Stretch-Triggered Drug Delivery from Wearable Elastomer Films Containing Therapeutic Depots.
J. Di (2015)
10.7324/JAPS.2015.50521
Development of Lipid Based Nanoparticulate Drug Delivery Systems and Drug Carrier Complexes for Delivery to Brain
S. Salunkhe (2015)
10.1039/b815918a
Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery.
Ahn Na Koo (2008)
10.1016/S0169-409X(97)00058-6
Anatomy, physiology and function of the nasal cavities in health and disease.
Dahl (1998)
10.1080/10611860500071292
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
T. Göppert (2005)
10.1016/j.ejps.2012.04.013
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
M. Fazil (2012)
10.1016/0009-2509(90)87019-O
Pressure-dependent phase transitions in hydrogels
K. Lee (1990)
10.1155/2013/238428
Nanoparticles for Brain Drug Delivery
M. Masserini (2013)
10.1021/nn300240p
Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.
R. Qiao (2012)
10.1016/j.ejpb.2010.11.022
Thermosensitive hydrogels for nasal drug delivery: the formulation and characterisation of systems based on N-trimethyl chitosan chloride.
H. Nazar (2011)
10.1016/j.biomaterials.2011.10.035
Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome.
Xiyang Sun (2012)
10.1016/J.COPBIO.2007.11.008
Nanotoxicity: the growing need for in vivo study.
H. C. Fischer (2007)
Nanocarriers may carry new hope for brain cancer therapy
L. Yarris (2015)
10.1007/s11095-015-1774-3
In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes
A. Lindqvist (2015)
10.1038/ncpneuro0289
Epidemiology and molecular pathology of glioma
Judith A Schwartzbaum (2006)
10.1080/10611860903112842
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
K. B. Kurakhmaeva (2009)
10.4103/0250-474X.22957
Fullerenes: An introduction and overview of their biological properties
S. Thakral (2006)
10.2174/1872211308666141028145651
Injectable thermosensitive chitosan/glycerophosphate-based hydrogels for tissue engineering and drug delivery applications: a review.
F. G. Tahrir (2015)
10.1016/j.wneu.2011.07.023
Epidemiology and the global burden of stroke.
D. Mukherjee (2011)
10.1016/j.addr.2011.12.006
Polymeric nanoparticles for drug delivery to the central nervous system.
T. Patel (2012)
Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring
M. B. Delgado-Charro (2001)
10.1117/12.2178134
Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system
N. McDannold (2015)
10.1016/j.addr.2009.03.007
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
10.2174/187221109787158355
CNS drug delivery systems: novel approaches.
S. A. Pathan (2009)
10.3109/10717544.2015.1094681
Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats
Sonali (2016)
10.1021/BM050313S
Physical gelation of chitosan in the presence of beta-glycerophosphate: the effect of temperature.
Jaepyoung Cho (2005)
10.1124/jpet.107.131318
Identification and Design of Peptides as a New Drug Delivery System for the Brain
M. Demeule (2008)
10.1002/CHIN.200748264
Solid Lipid Nanoparticles for Targeted Brain Drug Delivery
P. Blasi (2007)
10.1126/science.218.4571.467
Collapse of Gels in an Electric Field
T. Tanaka (1982)
10.1016/j.resp.2008.05.002
Air-conditioning in the human nasal cavity
D. Elad (2008)
10.1007/BF03165789
Stroke pathophysiology: management challenges and new treatment advances
J. Jordan (2009)
10.1016/j.colsurfb.2008.10.020
Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan.
Dong-hyuk Seo (2009)
10.1007/s11095-010-0141-7
Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis
H. Yang (2010)
10.1016/S0168-3659(00)00356-4
Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
Y. Kato (2001)
10.1016/j.ejpb.2007.11.002
Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting.
J. L. Arias (2008)
Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
G. Choe (2002)
10.1038/srep07085
Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: Pulmonary compatible and site-specific drug delivery in lung metastases
Nitin Joshi (2014)
10.3109/07357907.2011.630050
Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
H. Mao (2012)
10.1016/j.addr.2011.10.007
Nanotechnological advances for the delivery of CNS therapeutics.
H. L. Wong (2012)
10.1016/j.jpsychires.2013.10.011
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.
S. Haque (2014)
10.2353/AJPATH.2007.070011
Genetic pathways to primary and secondary glioblastoma.
H. Ohgaki (2007)
10.1073/PNAS.93.24.14164
Brain drug delivery of small molecules using immunoliposomes.
J. Huwyler (1996)
10.1016/j.ejps.2011.07.007
Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
H. Chen (2011)
10.1002/ijc.22296
Aclarubicin‐loaded cationic albumin‐conjugated pegylated nanoparticle for glioma chemotherapy in rats
W. Lu (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar